Home›Methocarbamol›Methocarbamol + Pyridostigmine Bromide

Does Methocarbamol Interact with Pyridostigmine Bromide?

Methocarbamol and Pyridostigmine Bromide have a major drug interaction according to U.S. FDA drug labeling data. Methocarbamol may inhibit the effect of pyridostigmine bromide. Patients with myasthenia gravis should be monitored closely for weakness symptoms; treatment should be stopped if observed. The mechanism involves inhibition of pyridostigmine bromide effect. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Major
Methocarbamol Class
Muscle Relaxant
Management
Close medical supervision required
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Methocarbamol and Pyridostigmine Bromide occurs because inhibition of pyridostigmine bromide effect. Clinically, this means methocarbamol may inhibit the effect of pyridostigmine bromide. patients with myasthenia gravis should be monitored closely for weakness symptoms; treatment should be stopped if observed. This is classified as a major interaction, meaning it could cause serious harm if not properly managed. Your healthcare provider may need to adjust dosages, substitute one medication, or increase monitoring frequency.

What To Tell Your Doctor or Pharmacist

If you are taking Methocarbamol and your doctor is considering prescribing Pyridostigmine Bromide (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask how frequently you should be monitored while these are co-prescribed
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Methocarbamol(Methocarbamol)+💊 Pyridostigmine Bromide(Regonol)

Severity & Interaction Details

⚠️
major
Use with caution — major interaction
Serious risk of clinically significant harm. Generally avoid; if used, monitor closely.
Severity scale
MinorContra
On record
Yes
Drug A class
Muscle Relaxant
Drug B class
—
Source
NLP:methocarbamol

What this means in plain English

Methocarbamol may inhibit the effect of pyridostigmine bromide. Patients with myasthenia gravis should be monitored closely for weakness symptoms; treatment should be stopped if observed.

What the FDA label says

"Inhibition of pyridostigmine bromide effect"

📖 Source: NLP:methocarbamol

Share this result:XFacebookWhatsAppReddit
Add more drugs
Check Methocarbamol and Pyridostigmine Bromide against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.